Virus-like particles as vaccines and vessels for the delivery of small molecules. Journal Article uri icon



  • Virus-like particles (VLPs) structurally mimic the viral capsid and have therefore been extensively, and quite successfully, used as vaccine and viral serology reagents. The ability of VLPs to include nucleic acids and small molecules has also made them novel vessels for gene and drug delivery. The regular, repetitive surface of VLPs has been exploited as a template for nanoscale synthesis. Recent progress has been made in the development of severalvirus models.

publication date

  • January 1, 2004

Date in CU Experts

  • October 1, 2013 11:25 AM

Full Author List

  • Garcea RL; Gissmann L

author count

  • 2

Additional Document Info

start page

  • 513-7

end page

  • 513-7


  • 15


  • 6